Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1970 Oct;67(2):765–772. doi: 10.1073/pnas.67.2.765

Serological and Immunogenic Activity of Soluble Mouse Transplantation Antigens Controlled by the H-2 Locus

Samuel Strober 1,*, Ettore Appella 1, Lloyd W Law 1
PMCID: PMC283271  PMID: 5289019

Abstract

The solubilization and partial purification of mouse transplantation antigens were monitored by (1) an in vitro assay for alloantigenic specificities and (2) an in vivo assay for transplantation antigens controlled by the H-2 histocompatibility locus. Antigens from A/J mice were solubilized by papain and fractionated on a Sephadex G-150 column. The eluate showed a 280 nm absorbance peak (F1) in the excluded volume and two peaks (F2 and F3) in the included volume. H-2 specificities 1, 3, 4, 5, 11, 23, and 28 were confined to a single peak in the F2 fraction.

Fractions F1, F2, and F3, were tested for their ability to accelerate skin graft rejection in noncoisogenic strains which differ at both H-2 and non-H-2 loci, and coisogenic strains which differ only at the H-2 locus. All fractions produced significant acceleration of graft rejection in the noncoisogenic strains, but only fraction F2 produced significant acceleration in the coisogenic strains. These findings indicate that H-2 transplantation antigens detected by our in vivo assay, and H-2 alloantigenic specificities detected by our in vitro assay are solubilized by papain and are eluted in the same peak during Sephadex fractionation.

Full text

PDF
765

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARNES A. D., KROHN P. L. The estimation of the number of histocompatibility genes controlling the successful transplantation of normal skin in mice. Proc R Soc Lond B Biol Sci. 1957 Jun 25;146(925):505–526. doi: 10.1098/rspb.1957.0027. [DOI] [PubMed] [Google Scholar]
  2. BASCH R. S., STETSON C. A. QUANTITATIVE STUDIES ON HISTOCOMPATIBILITY ANTIGENS OF THE MOUSE. Transplantation. 1963 Oct;1:469–480. doi: 10.1097/00007890-196301040-00004. [DOI] [PubMed] [Google Scholar]
  3. BILLINGHAM R. E., BRENT L., MEDAWAR P. B. Extraction of antigens causing transplantation immunity. Transplant Bull. 1958 Oct;5(4):377–381. doi: 10.1097/00006534-195810000-00034. [DOI] [PubMed] [Google Scholar]
  4. BILLINGHAM R. E., BRENT L., MEDAWAR P. B. The antigenic stimulus in transplantation immunity. Nature. 1956 Sep 8;178(4532):514–519. doi: 10.1038/178514a0. [DOI] [PubMed] [Google Scholar]
  5. Cherry M., Hilgert I., Kandutsch A. A., Snell G. D. Effects of proteolytic enzymes on murine H-2 antigens. Transplant Proc. 1970 Mar;2(1):48–58. [PubMed] [Google Scholar]
  6. Davies D. A. The molecular individuality of different mouse H-2 histocompatibility specificities determined by single genotypes. Transplantation. 1969 Jul;8(1):51–70. doi: 10.1097/00007890-196907000-00007. [DOI] [PubMed] [Google Scholar]
  7. Edidin M. The release of soluble H-2 alloantigens during disaggregation of mouse embryo tissue by a chelating agent. J Embryol Exp Morphol. 1966 Dec;16(3):519–530. [PubMed] [Google Scholar]
  8. GORER P. A., MIKULSKA Z. B., O'GORMAN P. The time of apperance of isoantibodies during the homograft response to mouse tumours. Immunology. 1959 Jul;2:211–218. [PMC free article] [PubMed] [Google Scholar]
  9. Graff R. J., Kandutsch A. A. Immunogenic properties of purified antigen preparations from a mouse sarcoma. Transplantation. 1966 Jul;4(4):465–473. doi: 10.1097/00007890-196607000-00010. [DOI] [PubMed] [Google Scholar]
  10. HERBERMAN R., STETSON C. A., Jr THE EXPRESSION OF HISTOCOMPATIBILITY ANTIGENS ON CELLULAR AND SUBCELLULAR MEMBRANES. J Exp Med. 1965 Apr 1;121:533–549. doi: 10.1084/jem.121.4.533. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. HERZENBERG L. A., HERZENBERG L. A. Association of H-2 antigens with the cell membrane fraction of mouse liver. Proc Natl Acad Sci U S A. 1961 Jun 15;47:762–767. doi: 10.1073/pnas.47.6.762. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. HILGERT I., CASTERMANS A., LEJEUNE G., VRANKEN M. ROLE OF DEBRIS OF TUMOUR ASCITIC FLUID IN TRANSPLANTATION IMMUNITY. Nature. 1964 Nov 14;204:704–705. doi: 10.1038/204704a0. [DOI] [PubMed] [Google Scholar]
  13. Hilgert I., Kandutsch A. A., Cherry M., Snell G. D. Fractionation of murine H-2 antigens with the use of detergents. Transplantation. 1969 Oct;8(4):451–461. doi: 10.1097/00007890-196910000-00016. [DOI] [PubMed] [Google Scholar]
  14. KAHAN B. D. ISOLATION OF A SOLUBLE TRANSPLANTATION ANTIGEN. Proc Natl Acad Sci U S A. 1965 Jan;53:153–161. doi: 10.1073/pnas.53.1.153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. KANDUTSCH A. A. Intracellular distribution and extraction of tumor homograft-enhancing antigens. Cancer Res. 1960 Feb;20:264–268. [PubMed] [Google Scholar]
  16. KANDUTSCH A. A., REINERT-WENCK U. Studies on a substance that promotes tumor homograft survival (the enhancing substance); its distribution and some properties. J Exp Med. 1957 Feb 1;105(2):125–139. doi: 10.1084/jem.105.2.125. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kahan B. D., Reisfeld R. A. Differences in the amino acid compositions of allogeneic guinea pig transplantation antigens. J Immunol. 1968 Aug;101(2):237–241. [PubMed] [Google Scholar]
  18. Kandutsch A. A., Jurgeleit H. C., Stimpfling J. H. The action of snake venom on an isoantigenic lipoprotein from a mouse sarcoma. Transplantation. 1965 Nov;3(6):748–761. doi: 10.1097/00007890-196511000-00006. [DOI] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. MANSON L. A., FOSCHI G. V., DOUGHERTY T., PALM J. MICROSOMAL LIPOPROTEINS AS TRANSPLANTATION ANTIGENS. Ann N Y Acad Sci. 1964 Nov 30;120:251–260. doi: 10.1111/j.1749-6632.1964.tb34723.x. [DOI] [PubMed] [Google Scholar]
  21. Mann D. L., Rogentine G. N., Jr, Fahey J. L., Nathenson S. G. Solubilization of human leucocyte membrane isoantigens. Nature. 1968 Mar 23;217(5134):1180–1181. doi: 10.1038/2171180a0. [DOI] [PubMed] [Google Scholar]
  22. Manson L. A., Foschi G. V., Palm J. IN VIVO AND IN VITRO STUDIES OF HISTOCOMPATIBILI ANTIGENS ISOLATED FROM A CULTURED MOUSE CELL LINE. Proc Natl Acad Sci U S A. 1962 Oct;48(10):1816–1822. doi: 10.1073/pnas.48.10.1816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Ozer J. H., Wallace D. F. H-2 components and cellular membranes: distinctions between plasma membrane and endoplasmic reticulum governed by the H-2 region in the mouse. Transplantation. 1967 Jul;5(4):652–667. [PubMed] [Google Scholar]
  24. SANDERSON A. R. CYTOTOXIC REACTIONS OF MOUSE ISO-ANTISERA: PRELIMINARY CONSIDERATIONS. Br J Exp Pathol. 1964 Aug;45:398–408. [PMC free article] [PubMed] [Google Scholar]
  25. STROBER S., GOWANS J. L. THE ROLE OF LYMPHOCYTES IN THE SENSITIZATION OF RATS TO RENAL HOMOGRAFTS. J Exp Med. 1965 Aug 1;122:347–360. doi: 10.1084/jem.122.2.347. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Shimada A., Nathenson S. G. Murine histocompatibility-2 (H-2) alloantigens. Purification and some chemical properties of soluble products from H-2b and H-2d genotypes released by papain digestion of membrane fractions. Biochemistry. 1969 Oct;8(10):4048–4062. doi: 10.1021/bi00838a023. [DOI] [PubMed] [Google Scholar]
  27. WIGZELL H. QUANTITATIVE TITRATIONS OF MOUSE H-2 ANTIBODIES USING CR-51-LABELLED TARGET CELLS. Transplantation. 1965 May;3:423–431. doi: 10.1097/00007890-196505000-00011. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES